Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22
Phase 31

Trial Status

Completed3

Role Distribution

Principal Investigator2
Other Roles1
PI Rate67%

Activity Timeline

Clinical Trials (3)

NCT03023111Phase 3Completed
Miltefosine and GM-CSF in Cutaneous Leishmaniasis
Cutaneous Leishmaniasis
PrincipalinvestigatorStart date: 2017-06-30
NCT03294161Phase 2Completed
Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis
LeishmaniasisLeishmaniasis, CutaneousLeishmaniasis; American
StudychairStart date: 2014-12-01
NCT00600548Phase 2Completed
Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil)
Treatment of Cutaneous Leishmaniasis in Brazil.
Principalinvestigator

Research Network

Collaboration Network

7 collaborators·9 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Edgar M Carvalho, MD, PhD

Federal University of Bahia

Moderately Similar
2 trials

Shared therapeutic areas:

LeishmaniasisLeishmaniasis; AmericanLeishmaniasis, Cutaneous

Worked with same sponsors:

Conselho Nacional de Desenvolvimento Científico e TecnológicoFederal University of Bahia+2 more
Collaborated on 1 trial
Similarity Score34%

Jaime Soto, MD

Fundacion Nacional de Dermatologia

Related
4 trials

Shared therapeutic areas:

Leishmaniasis, CutaneousLeishmaniasisLeishmaniasis; American
Similarity Score23%

Wim Adriaensen, PhD

Institute of Tropical Medicine Antwerp

Related
2 trials

Shared therapeutic areas:

Leishmaniasis, CutaneousLeishmaniasis
Similarity Score15%

Franco Piazza, MD, MPH

Access to Advanced Health Institute (AAHI)

Related
6 trials

Shared therapeutic areas:

Leishmaniasis, CutaneousLeishmaniasis
Similarity Score15%

Edgar M Carvalho, MD, PhD

Instituto Fernandes Figueira

Related
1 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous

Worked with same sponsors:

Hospital Universitário Professor Edgard SantosOswaldo Cruz Foundation
Collaborated on 1 trial
Similarity Score14%

Gerson Penna, MD, PhD

Instituto Fernandes Figueira

Related
1 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous

Worked with same sponsors:

Hospital Universitário Professor Edgard SantosOswaldo Cruz Foundation
Collaborated on 1 trial
Similarity Score14%

Manoel Barral Neto, MD, PhD

Instituto Fernandes Figueira

Related
1 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous

Worked with same sponsors:

Hospital Universitário Professor Edgard SantosOswaldo Cruz Foundation
Collaborated on 1 trial
Similarity Score14%

Marcos López, PhD

The University of Akron

Related
2 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score8%

Paulo Machado

Federal University of Bahia

Related
1 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score8%

Patricio López-Jaramillo, MD, PhD

Cardiovascular Foundation of Colombia

Related
1 trials

Shared therapeutic areas:

Leishmaniasis, Cutaneous
Similarity Score8%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT03023111Phase 3PrincipalInvestigator

Miltefosine and GM-CSF in Cutaneous Leishmaniasis

Cutaneous Leishmaniasis
Completed
NCT03294161Phase 2StudyChair

Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis

LeishmaniasisLeishmaniasis, CutaneousLeishmaniasis; American
Completed
NCT00600548Phase 2PrincipalInvestigator

Trial of Miltefosine in Cutaneous Leishmaniasis (Brazil)

Treatment of Cutaneous Leishmaniasis in Brazil.
Completed

All 3 trials loaded